Is a complete NRIX research report available?

No complete published report is available for Nurix Therapeutics, Inc. (NRIX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Nurix Therapeutics, Inc. (NRIX)

NASDAQ: NRIX · USD

$23.7

+0.14 (+0.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NRIX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.5B
Revenue (ttm)	36.8M
Net income (ttm)	-341.4M
EPS (ttm)	-$3.41
Shares out	103.8M
Volume	965,869
Beta	1.80
Price target	$33.0	+39.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 36.8M
Net income (ttm): -341.4M
EPS (ttm): -$3.41
Market cap: 2.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NRIX indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001549595
Company name	Nurix Therapeutics, Inc.
Country	United States
Country code	US
Cusip	67080M103
Employees	317
Employees Change	31%
Employees Change Percent	10.84
Enterprise value	$2.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-07-24
Isin	US67080M1036
Last refreshed	2026-07-24
Market cap	$2.5B
Market cap category	Mid-Cap
Price	$23.74
Price currency	USD
Rev Per Employee	115,981.07x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2834
Symbol	NRIX
Website	https://www.nurixtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.85%
EV Sales Forward	11.42x
EV/Sales	56.53x
FCF yield	-12.36%
P/B ratio	6.11x
P/S ratio	67.01x
PS Forward	13.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-982.37%
EBITDA Margin	-953.31%
Gross Profit	$-304.2M
Net Income	$-341.4M
Net Income Growth Years	0%
Pretax Margin	-929.18%
Profit Per Employee	$-1.1M
ROA	-40.06
Roa5y	-24
ROCE	-77.92
ROE	-80.3
Roe5y	-50.57
ROIC	-47.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	111.13%
Cagr3y	33.08%
Cagr5y	-5%
EPS Growth Years	0
Revenue Growth	-58.4x
Revenue Growth Q	-79.47x
Revenue Growth Years	1x
Revenue Growth3 Y	-15.5x
Revenue Growth5 Y	9.95x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.07
Assets	$535.5M
Cash	$443.5M
Current Assets	$456.5M
Current Liabilities	$72M
Debt	$58.1M
Debt Equity	$0.14
Equity	$402.6M
Liabilities	$132.9M
Long Term Assets	$79.1M
Long Term Liabilities	$60.9M
Net Cash	$385.4M
Net Cash By Market Cap	$15.64
Net Cash Growth	-11.17%
Net Debt Equity	$-0.96
Tangible Book Value	$402.6M
Tangible Book Value Per Share	$3.88
WACC	13.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.34
Net Working Capital	$-55.8M
Quick ratio	6.18
Working Capital	$384.5M
Working Capital Turnover	$0.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-25.67%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	111.02%
200-day SMA	16.68
3Y total return	135.75%
50-day SMA	19.46
50-day SMA vs 200-day SMA	50over200
5Y total return	-22.62%
All Time High	52.38
All Time High Change	-54.68%
All Time High Date	2020-12-14
All Time Low	4.22
All Time Low Change	462.56%
All Time Low Date	2023-10-26
ATR	1.26
Beta	1.8
Beta1y	0.45
Beta2y	1.3
Ch YTD	25.15
High	24.17
High52	25.09
High52 Date	2026-07-09
High52ch	-5.36%
Low	22.87
Low52	8.2
Low52 Date	2025-09-23
Low52ch	189.69%
Ma50ch	22.01%
Premarket Change Percent	0
Premarket Price	$23.6
Premarket Volume	3,787
Price vs 200-day SMA	42.29%
RSI	63.61
RSI Monthly	63.44
RSI Weekly	69.45
Sharpe ratio	1.44x
Sortino ratio	2.64
Total Return	-25.67%
Tr YTD	25.15
Tr1m	27.29%
Tr1w	2.9%
Tr3m	42.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	15
Analyst Count Top	12
Analyst Price Target Top	$33.45
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.72
Earnings Revenue Estimate	15,091,144x
Earnings Revenue Estimate Growth	-65.75x
Operating Income	$-361.2M
Operating margin	-982.4
Price target	$33
Price Target Change	$39.01
Price Target Change Top	$40.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	82,785,939%
Float Percent	79.77%
Shares Insiders	0.5%
Shares Institutions	92.5%
Shares Out	103,781,683
Shares Qo Q	0.92%
Shares Yo Y	25.67%
Short Float	21.5%
Short Ratio	4.72
Short Shares	17.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-344.2M
Average Volume	1,820,350.8x
Bv Per Share	3.88
CAPEX	$-10.8M
Ch1m	27.29
Ch1w	2.9
Ch1y	111
Ch3m	42.75
Ch3y	135.8
Ch5y	-22.62
Ch6m	22.43
Change	0.59%
Change From Open	1.37
Close	23.6
Days Gap	-0.76
Depreciation Amortization	7,999,000
Dollar Volume	22,929,730.1
Earnings Date	2026-07-09
Earnings Time	amc
EBIT	$-361.2M
EBITDA	$-350.5M
EPS	$-3.41
F Score	1
FCF	$-304.5M
FCF EV Yield	-14.65x
FCF Per Share	$-2.93
Financing CF	257,204,000
Fiscal Year End	November
Founded	2,009
Income Tax	$-271,000
Investing CF	19,992,000
Ipr	24.95
Iprfo	31.45
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-09
Last Report Date	2026-05-31
Last Split Type	Never
Last10k Filing Date	2026-01-28
Ma150	17.69
Ma150ch	34.2%
Ma20	23.56
Ma20ch	0.78%
Net CF	-16,508,000
Next Earnings Date	2026-10-08
Open	23.42
Optionable	Yes
Position In Range	66.92
Ppne	70,114,000
Pre Close	23.6
Price Date	2026-07-23
Ptbv Ratio	6.12
Relative Volume	0.53x
Revenue	36,766,000x
SBC By Revenue	107.84x
Share Based Comp	39,650,000
Tax By Revenue	-0.74x
Tr6m	22.43%
Us State	California
Volume	965,869
Z Score	1.62

Nurix Therapeutics, Inc. (NRIX)

Coverage state: Market snapshot only — no published research

Generate the first NRIX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · NRIX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NRIX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NRIX

Frequently asked questions